ASLN
ASLN Stock Analysis Overview
What this means: Aslan Pharmaceuticals Ltd ADR (ASLN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ASLN's 57 means that it ranks higher than 57% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
ASLN Stock Analysis Overview
What this means: Aslan Pharmaceuticals Ltd ADR (ASLN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ASLN's 57 means that it ranks higher than 57% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
ASLN Stock Analysis Overview
What this means: Aslan Pharmaceuticals Ltd ADR (ASLN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ASLN's 57 means that it ranks higher than 57% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
ASLN Stock Analysis Overview
What this means: Aslan Pharmaceuticals Ltd ADR (ASLN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ASLN's 57 means that it ranks higher than 57% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
ASLN Stock Analysis Overview
What this means: Aslan Pharmaceuticals Ltd ADR (ASLN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ASLN's 57 means that it ranks higher than 57% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
ASLN Stock Analysis Overview
What this means: Aslan Pharmaceuticals Ltd ADR (ASLN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ASLN's 57 means that it ranks higher than 57% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
ASLN Stock Analysis Overview
What this means: Aslan Pharmaceuticals Ltd ADR (ASLN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ASLN's 57 means that it ranks higher than 57% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
ASLN Stock Analysis Overview
What this means: Aslan Pharmaceuticals Ltd ADR (ASLN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ASLN's 57 means that it ranks higher than 57% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
Aslan Pharmaceuticals Ltd ADR (ASLN) Analyst Forecast
- Last Price$1.75
- Previous Close$1.84
- Change
$-0.09 - Open$1.85
- Volume62,568
- Avg. Volume (100-day)190,444
- Market Capitalization$66M
- Days Range
$1.70 - $1.85 - 52-week Range
$0.35 - $8.18 - Dividend Yield—
- Ex. Dividend Date—
- P-E—
- EPS-1.41
- Earnings Date10/29/2020
- SectorHealthcare
- IndustryBiotechnology
- Avg. Analyst Rec.
- Beta0.902
- PEG Ratio—